Literature DB >> 8557038

Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1.

D J O'Connor1, E W Lam, S Griffin, S Zhong, L C Leighton, S A Burbidge, X Lu.   

Abstract

One way in which wild-type p53 is able to regulate cell cycle progression is thought to be via the induction of its downstream target gene Waf1/CIP1, thus indirectly regulating the transcriptional activity of E2F. The E2F transcription factors are known to be key effectors of the cell cycle. We report here that there is a physical and functional interaction between p53 and two of the components of the E2F transcription factors, E2F1 and DP1. The expression of wild-type p53 can inhibit the transcriptional activity of E2F, and the expression of both E2F1 and DP1 can also downregulate p53-dependent transcription. The transcriptional activity of p53 is known to be inhibited by the direct binding of mdm2, but we demonstrate here that both E2F1 and DP1 can inhibit p53 transcriptional activity independently of mdm2. Detailed studies of protein-protein interactions have provided evidence that E2F1 and its co-operating factor DP1 can complex with p53 both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557038      PMCID: PMC394743          DOI: 10.1002/j.1460-2075.1995.tb00309.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

3.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.

Authors:  J Y Shew; B T Lin; P L Chen; B Y Tseng; T L Yang-Feng; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

5.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

6.  The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.

Authors:  D W Meek; S Simon; U Kikkawa; W Eckhart
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

7.  Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.

Authors:  G Casey; M Lo-Hsueh; M E Lopez; B Vogelstein; E J Stanbridge
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

8.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

9.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

10.  Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.

Authors:  C A Midgley; C J Fisher; J Bártek; B Vojtĕsek; D Lane; D M Barnes
Journal:  J Cell Sci       Date:  1992-01       Impact factor: 5.285

View more
  25 in total

Review 1.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

2.  Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.

Authors:  Takahito Nakagawa; Masato Takahashi; Toshinori Ozaki; Ken-ichi Watanabe Ki; Satoru Todo; Hiroyuki Mizuguchi; Takao Hayakawa; Akira Nakagawara
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression.

Authors:  Brygida Bisikirska; Mukesh Bansal; Yao Shen; Julie Teruya-Feldstein; Raju Chaganti; Andrea Califano
Journal:  Cancer Res       Date:  2015-11-20       Impact factor: 12.701

4.  Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.

Authors:  Valentina Fogal; Jung-Kuang Hsieh; Christophe Royer; Shan Zhong; Xin Lu
Journal:  EMBO J       Date:  2005-07-21       Impact factor: 11.598

5.  Inhibition of E2F-mediated transcription by p202.

Authors:  D Choubey; S J Li; B Datta; J U Gutterman; P Lengyel
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

6.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

7.  Distinct roles for E2F proteins in cell growth control and apoptosis.

Authors:  J DeGregori; G Leone; A Miron; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

8.  Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.

Authors:  D S Park; E J Morris; R Bremner; E Keramaris; J Padmanabhan; M Rosenbaum; M L Shelanski; H M Geller; L A Greene
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

9.  ATM-dependent E2F1 accumulation in the nucleolus is an indicator of ribosomal stress in early response to DNA damage.

Authors:  Ya-Qiong Jin; Guo-Shun An; Ju-Hua Ni; Shu-Yan Li; Hong-Ti Jia
Journal:  Cell Cycle       Date:  2014-03-25       Impact factor: 4.534

10.  Functional interaction between DP-1 and p53.

Authors:  T S Sørensen; R Girling; C W Lee; J Gannon; L R Bandara; N B La Thangue
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.